Effectiveness of controlled-release budesonide in preserving bone mineral density in patients with Crohn's disease.
Abreu
Maria T
MT
Center for Inflammatory Bowel Disease, Mount Sinai School of Medicine, New York, NY 10029, USA. maria.abreu@mssm.edu
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects*; D019819:Budesonide / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D004311:Double-Blind Method; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D010024:Osteoporosis / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control; D011239:Prednisolone / Q000627:therapeutic use; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D003692:Delayed-Action Preparations; D005938:Glucocorticoids; D019819:Budesonide; D011239:Prednisolone